European Neural Implants Market to Hit $6.28 Billion by 2035 Owing to Technological Advancement

European neural implants market is projected to reach $6.28 billion by 2035 from $1.89 billion in 2024, growing at a CAGR of 11.5% during the forecast period (2025–2035). With the technological advancements, the European neural implant market is entering a new paradigm.

From one-size-fits-all to patient-specific 3D design, technological advancements are becoming a game-changer for this market. 3D-printed cranial implants are reducing post-surgery complications; on the other hand, less invasive surgeries are encouraging patients to go for neural implants and the usage of biocompatible materials, including PEEK and titanium, is improving performance and safety.

Browse the full report description of “European Neural Implants Market Size, Share & Trends Analysis Report by Product (Deep Brain Stimulation (DCS), Spinal Cord Stimulation (SCS), and Vagus Nerve Stimulation (VNS)), by Application (Chronic Pain, Epilepsy, Parkinson's Disease (PD), and Others (Depression and Other Movement Disorders)), and by End-user (Hospitals, Outpatient Surgery Centers, and Specialized Neurological Centers (SNCs)), Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/europe-neural-implants-market

Furthermore, the integration of AI in neural implant technology is also transforming the scenario of this market. Real-time monitoring through an AI algorithm helps in adjusting electrical pulses only when needed, which in turn gives efficient results to the patients.

But the medtech innovations are not limited to this only; now, companies are focusing on developing technologies to avoid open brain surgery for neural implants and are trying different ways to perform this critical task while focusing on minimally invasive surgical techniques. For instance, Synchron has developed technology, namely Stentrode, a device which can make neural implants possible through blood vessels.

Recent Business Development in Neural Implants Market

• November 2025: Synchron, Inc. raised $200 million to advance its work of building brain implants which can be inserted through blood vessels.

• December 2025: CorTec GmbH announced the first human implantation of its proprietary BCI system, Brain Interchange. The press release highlights clinical progress toward real-world therapeutic applications of their advanced implantable technology. This marks clinical progress toward real-world therapeutic applications of their advanced implantable technology.

• December 2025, Synergia Medical announced that its VNS neuromodulation device met the primary safety endpoint in the AURORA first-in-human clinical study after successful implantation in five patients in Belgium. Their device features a metal-free design, offering immunity to electromagnetic interference and full MRI compatibility, along with a fast-recharge battery designed for long operational life. And now the company is planning to seek the US FDA approval for the same.

Industry Response

Companies are significantly focusing on advancing their technology with AI integration and trying to make neural implantation possible through minimally invasive surgery. So that the fear of brain surgery can be eliminated, and patients can adopt the neural implant route to get efficient results and relief in their disease.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
• Product
• Application
• End-User

• Competitive Landscape – CorTec GmbH, Aleva Neurotherapeutics SA, Neuro France Implants, NeuroPace Inc., and LivaNova PLC.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

European Neural Implants Market Report Segment

By Product

• Deep Brain Stimulation (DCS)
• Spinal Cord Stimulation (SCS)
• Vagus Nerve Stimulation (VNS)

By Application

• Chronic Pain
• Epilepsy
• Parkinson's Disease (PD)
• Others (Depression and Other Movement Disorders)

By End-User

• Hospitals
• Outpatient Surgery Centers
• Specialized Neurological Centers (SNCs)

European Neural Implants Market Report Segment by Region

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/europe-neural-implants-market